Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

10.69
Delayed Data
As of Jun 22
 -0.29 / -2.64%
Today’s Change
8.75
Today|||52-Week Range
15.45
+2.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues39.3M32.3M41.7M51.2M
 
 
 
 
 
Cost of Goods Sold3.7M2.7M2.5M3.5M
 
 
 
 
 
Depreciation And Amortization4.0M3.9M2.8M816.6K
 
 
 
 
 
 
Operating ExpensesGross Income31.6M25.7M36.3M46.9M
 
 
 
 
 
General Expenses19.1M21.0M23.4M18.6M
 
 
 
 
 
Research And Development7.7M8.2M13.0M7.0M
 
 
 
 
 
Total Operating Expenses26.8M27.6M28.7M22.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income12.5M4.7M12.9M28.3M
 
 
 
 
 
Extraordinary Credit0.000.003.6M6.8M
 
 
 
Extraordinary Charge-24.2M-21.0M0.00-2.6M
 
 
 
 
Interest Expense On Debt266.2K265.8K252.4K256.6K
 
 
 
 
 
Other Expenses-1.1M-2.9M1.2M1.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.7M-19.0M17.5M33.6M
 
 
 
 
 
Income Taxes-7.5M-3.5M-12.9M-8.3M
 
 
 
 
 
Net Income-20.2M-22.5M4.6M25.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.2M41.2M41.3M41.4M
 
 
 
 
 
Shares To Calculate EPS Diluted41.2M41.2M42.8M42.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.49-$0.54$0.11$0.61
 
 
 
 
 
EPS Diluted-$0.49-$0.54$0.11$0.60